Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Sunitinib in Metastatic Renal Cell Carcinoma: A Systematic Review of UK Real World Data.

Argyropulo-Palmer M, Jenkins A, Theti DS, Larkin J, Montgomery D.

Front Oncol. 2015 Aug 25;5:195. doi: 10.3389/fonc.2015.00195. eCollection 2015.

2.

Targeting the alpha-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase.

Henderson EA, Bavetsias V, Theti DS, Wilson SC, Clauss R, Jackman AL.

Bioorg Med Chem. 2006 Jul 15;14(14):5020-42. Epub 2006 Mar 22.

PMID:
16554160
3.

BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.

Gibbs DD, Theti DS, Wood N, Green M, Raynaud F, Valenti M, Forster MD, Mitchell F, Bavetsias V, Henderson E, Jackman AL.

Cancer Res. 2005 Dec 15;65(24):11721-8.

4.

Antifolates targeted specifically to the folate receptor.

Jackman AL, Theti DS, Gibbs DD.

Adv Drug Deliv Rev. 2004 Apr 29;56(8):1111-25. Review.

PMID:
15094210
5.
6.
7.

A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours.

Jackman AL, Melin CJ, Kimbell R, Brunton L, Aherne GW, Theti DS, Walton M.

Biochim Biophys Acta. 2002 Jul 18;1587(2-3):215-23. Review.

8.

Cyclopenta[g]quinazoline-based antifolates: the effect of the chirality at the 6-position on the inhibition of thymidylate synthase (TS).

Bavetsias V, Marriott JH, Theti DS, Melin JC, Wilson SC, Jackman AL.

Bioorg Med Chem Lett. 2001 Dec 3;11(23):3015-7.

PMID:
11714600

Supplemental Content

Loading ...
Support Center